Serine 403-phosphorylated p62/SQSTM1 immunoreactivity in inclusions of neurodegenerative diseases

Masaru Kurosawa1, Gen Matsumoto2, Hiroyuki Sumikura3

  • 1Laboratory for Structural Neuropathology, RIKEN Brain Science Institute, Saitama 351-0198, Japan; Laboratory for Molecular Mechanisms of Thalamus Development, RIKEN Brain Science Institute, Saitama 351-0198, Japan; Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan; CREST (Core Research for Evolutionary Science and Technology), JST, Tokyo 102-0076, Japan.

Neuroscience Research
|August 26, 2015
PubMed